- C. 24 million shares to be sold
STOCKHOLM, Dec. 8, 2025 /PRNewswire/ — Further to previous announcements, an affiliate of the funds known as EQT VIII (“EQT“) is pleased to announce it has signed an agreement to sell c. 24 million shares in Galderma Group AG (SIX: GALD) (the “Company“) to L’Oréal S.A at an undisclosed premium (the “Sale“). Out of the total shares to be sold, c. 6 million are attributable to EQT.
The closing of the Sale is subject to customary regulatory approvals.
Contact
EQT Press Office, press@eqtpartners.com
Important notice
This press release does not constitute (i) an offer to sell or a solicitation of an offer to buy any securities of Galderma Group AG or any of its affiliates and it does not constitute a prospectus within the meaning of the Swiss Financial Services Act or (ii) an offer of securities for sale in the United States or elsewhere. Securities may not be offered or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration. There will be no public offering of any of the securities mentioned in this press release in the United States.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
|
Press Release, EQT VIII, Galderma, 08122025 |
View original content:https://www.prnewswire.com/news-releases/eqt-agrees-to-sale-of-shares-in-galderma-group-ag-to-loreal-sa-302635098.html
SOURCE EQT
